ResMed Inc $ 134.53 1.02 (0.76%)
| Volume: | 761,740 | Avg Vol (1m): | 546,495 |
| Market Cap $: | 19.33 Bil | Enterprise Value $: | 20.45 Bil |
| P/E (TTM): | 48.05 | P/B: | 9.30 |
Manual of Stocks™ Web
Financial Strength | 6.2/10 |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Cash-To-Debt | 0.12 | ||
| Equity-to-Asset | 0.5 | ||
| Debt-to-Equity | 0.61 | ||
| Debt-to-EBITDA | 1.8 | ||
| Interest Coverage | 17.59 | ||
| Piotroski F-Score | 6 | ||
| Altman Z-Score | 7.78 | ||
| Beneish M-Score | -2.54 | ||
| WACC vs ROIC | |||
Profitability |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Operating Margin % | 24.4 | ||
| Net Margin % | 15.52 | ||
| ROE % | 20.21 | ||
| ROA % | 11.12 | ||
| ROC (Joel Greenblatt) % | 66.14 | ||
| 3-Year Revenue Growth Rate | 11.6 | ||
| 3-Year EBITDA Growth Rate | 8.8 | ||
| 3-Year EPS without NRI Growth Rate | 4 |
Ratios |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| PE Ratio | 48.05 | ||
| Forward PE Ratio | 39.84 | ||
| PE Ratio without NRI | 48.05 | ||
| Price-to-Owner-Earnings | 59.79 | ||
| PB Ratio | 9.3 | ||
| PS Ratio | 7.45 | ||
| Price-to-Free-Cash-Flow | 50.92 | ||
| Price-to-Operating-Cash-Flow | 42.33 | ||
| EV-to-EBIT | 36.85 | ||
| EV-to-EBITDA | 28.98 | ||
| EV-to-Revenue | 7.85 | ||
| PEG Ratio | 6.76 | ||
| Shiller PE Ratio | 58.62 | ||
| Current Ratio | 2.06 | ||
| Quick Ratio | 1.43 | ||
| Days Inventory | 103.52 | ||
| Days Sales Outstanding | 74 | ||
| Days Payable | 39.48 |
Dividend & Buy Back |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Dividend Yield % | 1.11 | ||
| Dividend Payout Ratio | 0.53 | ||
| 3-Year Dividend Growth Rate | 7.2 | ||
| Forward Dividend Yield % | 1.16 | ||
| 5-Year Yield-on-Cost % | 1.65 | ||
| 3-Year Average Share Buyback Ratio | -0.8 |
Valuation & Return |
| Current | Vs Industry | Vs History | |
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 2.89 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 3.32 | ||
| Price-to-Median-PS-Value | 1.62 | ||
| Price-to-Peter-Lynch-Fair-Value | 6.1 | ||
| Earnings Yield (Greenblatt) % | 2.71 | ||
| Forward Rate of Return (Yacktman) % | 9.9 |